Equibles does not estimate personal net worth.
Get an email with a short summary when Arcutis Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARQT alertsFrank Watanabe is recorded as CEO at Arcutis Biotherapeutics, Inc. (ARQT). Frank Watanabe has spoken on 16 earnings calls and 4 other investor events across 1 company, most recently for Arcutis Biotherapeutics, Inc. on September 16, 2026. Arcutis Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arcutis Biotherapeutics, Inc. includes Todd Franklin Watanabe (CEO and Board Member), Latha Vairavan (CFO), Masaru Matsuda (General Counsel) and 7 others.
“Yeah, so we just celebrated our 10th anniversary in June, and I have my 10th anniversary in like six weeks. I think it's coming up pretty fast. So the company was actually founded by Fraser Healthcare.”
“As always, we appreciate you guys making the time to join us on our quarterly update call.”
“Yeah, I mean, look, I think that everything is going very well from our perspective at Arcutis. You know, Zarif continues to grow very strongly. We had another very strong quarter last quarter.”
“As always, we appreciate you guys making the time to join us. I want to start today's call with an overview of the latest developments at Arcudis and the progress we're making against our Grow, Expand, Build strategy.”
“So for those of you who aren't familiar, Arcutis Biotherapeutics is a 10-year-old dermatology biotech. We focus on the treatment of inflammatory skin conditions.”
Biotechnology · Healthcare
CEO
